351 related articles for article (PubMed ID: 15936740)
1. Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression.
Danson EJ; Zhang YH; Sears CE; Edwards AR; Casadei B; Paterson DJ
Cardiovasc Res; 2005 Sep; 67(4):613-23. PubMed ID: 15936740
[TBL] [Abstract][Full Text] [Related]
2. Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation.
Martin SR; Emanuel K; Sears CE; Zhang YH; Casadei B
Cardiovasc Res; 2006 Apr; 70(1):97-106. PubMed ID: 16545353
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase.
Vandecasteele G; Eschenhagen T; Scholz H; Stein B; Verde I; Fischmeister R
Nat Med; 1999 Mar; 5(3):331-4. PubMed ID: 10086391
[TBL] [Abstract][Full Text] [Related]
4. Role of G(i/o)-Src kinase-PI3K/Akt pathway and caveolin-1 in β₂-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery.
Banquet S; Delannoy E; Agouni A; Dessy C; Lacomme S; Hubert F; Richard V; Muller B; Leblais V
Cell Signal; 2011 Jul; 23(7):1136-43. PubMed ID: 21385608
[TBL] [Abstract][Full Text] [Related]
5. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of (Gialpha) proteins increases arrhythmogenic effects of beta-adrenergic stimulation in the heart.
Grimm M; Gsell S; Mittmann C; Nose M; Scholz H; Weil J; Eschenhagen T
J Mol Cell Cardiol; 1998 Oct; 30(10):1917-28. PubMed ID: 9799646
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction.
Massion PB; Dessy C; Desjardins F; Pelat M; Havaux X; Belge C; Moulin P; Guiot Y; Feron O; Janssens S; Balligand JL
Circulation; 2004 Oct; 110(17):2666-72. PubMed ID: 15492314
[TBL] [Abstract][Full Text] [Related]
8. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart.
Zhang ZS; Cheng HJ; Onishi K; Ohte N; Wannenburg T; Cheng CP
J Pharmacol Exp Ther; 2005 Dec; 315(3):1203-11. PubMed ID: 16135702
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response.
Sterin-Borda L; Bernabeo G; Ganzinelli S; Joensen L; Borda E
J Mol Cell Cardiol; 2006 Apr; 40(4):580-8. PubMed ID: 16510153
[TBL] [Abstract][Full Text] [Related]
10. Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion.
Okoshi K; Nakayama M; Yan X; Okoshi MP; Schuldt AJ; Marchionni MA; Lorell BH
Circulation; 2004 Aug; 110(6):713-7. PubMed ID: 15289373
[TBL] [Abstract][Full Text] [Related]
11. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
12. Inotropic response of cardiac ventricular myocytes to beta-adrenergic stimulation with isoproterenol exhibits diurnal variation: involvement of nitric oxide.
Collins HE; Rodrigo GC
Circ Res; 2010 Apr; 106(7):1244-52. PubMed ID: 20167926
[TBL] [Abstract][Full Text] [Related]
13. Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels.
Endou M; Poli E; Levi R
J Pharmacol Exp Ther; 1994 Apr; 269(1):221-9. PubMed ID: 8169830
[TBL] [Abstract][Full Text] [Related]
14. Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3.
Champion HC; Georgakopoulos D; Takimoto E; Isoda T; Wang Y; Kass DA
Circ Res; 2004 Mar; 94(5):657-63. PubMed ID: 14752030
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases.
Khan SA; Skaf MW; Harrison RW; Lee K; Minhas KM; Kumar A; Fradley M; Shoukas AA; Berkowitz DE; Hare JM
Circ Res; 2003 Jun; 92(12):1322-9. PubMed ID: 12764022
[TBL] [Abstract][Full Text] [Related]
16. Increased eNOS expression as a compensatory mechanism reducing beta-adrenergic responsiveness?
Müller FU
Cardiovasc Res; 2005 Sep; 67(4):575-7. PubMed ID: 16004978
[No Abstract] [Full Text] [Related]
17. Myocyte nitric oxide synthase 2 contributes to blunted beta-adrenergic response in failing human hearts by decreasing Ca2+ transients.
Ziolo MT; Maier LS; Piacentino V; Bossuyt J; Houser SR; Bers DM
Circulation; 2004 Apr; 109(15):1886-91. PubMed ID: 15037528
[TBL] [Abstract][Full Text] [Related]
18. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
[TBL] [Abstract][Full Text] [Related]
19. Galpha(i2), Galpha(i3)and Galpha(o) are all required for normal muscarinic inhibition of the cardiac calcium channels in nodal/atrial-like cultured cardiocytes.
Ye C; Sowell MO; Vassilev PM; Milstone DS; Mortensen RM
J Mol Cell Cardiol; 1999 Sep; 31(9):1771-81. PubMed ID: 10471359
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cardiac L-type calcium current response to beta2-adrenergic stimulation in heart failure.
Zhang ZS; Cheng HJ; Ukai T; Tachibana H; Cheng CP
J Pharmacol Exp Ther; 2001 Jul; 298(1):188-96. PubMed ID: 11408541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
